Milner Therapeutics to establish new genomics laboratory for drug discovery
The new state-of-the-art facility is set to be operational in early 2024
Read More
Tag: Genomics
Genomics plc scores $30m to expand patient-centric health platform
Latest funding round includes investments from Foresite Capital and F-Prime Capital
Read More
GSK, Uni of California pair up to advance genomic research
The LGR will receive up to $67 million in funding over a five-year period.
Read More
Genomics England completes first phase of liquid biopsy study
The results will enable researchers to perform an objective technology evaluation of the various market offerings in liquid biopsy in the second stage.
Read More
Cancer Research and AstraZeneca launch genomics centre
Cancer Research UK and AstraZeneca have announced that they are opening a new centre in Cambridge, UK, dedicated to realising the full potential of functional genomics in the discovery and development of new drugs for patients with cancer.
Read More
Cardiff Uni and Takeda team up for new drug discovery collaboration
Cardiff University has formed a drug discovery collaboration with Takeda to identify new approaches for treating schizophrenia and other psychiatric disorders.
Read More
Vertex invests in Genomics plc as the firms sign research deal
UK analytics group Genomics plc has signed a three-year deal with Vertex centred on improving the discovery of targets for precision medicine, and has also raised £25 million to further expand its business.
Read More
- MRM Health collaborates with Oncode Institute and Netherlands Cancer Institute
- Sobi to acquire Arthrosi Therapeutics, strengthening gout treatment pipeline
- Lindus Health and Quotient Sciences announce strategic partnership to accelerate drug development
- Title21 Health Solutions joins the Blood and Cells Advocacy Roster
- NADMED launches $30,000 metabolomics research award
